CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

amyotrophic lateral sclerosis

University of Michigan Hospital (University of Michigan photo)

ALS Patients Approved For More Stem Cells

Three patients with amyotrophic lateral sclerosis will be permitted to receive a second dose of stem cells delivered directly to the spinal cord, in a clinical trial being led by the University of Michigan’s Eva Feldman, M.D.

WWJ Newsradio 950–05/09/2012

Synthetics Biologics

Synthetic Biologics Launches Free Investor Relations Mobile Application

Synthetic Biologics Inc. (NYSE Amex: SYN) Thursday announced the release of its investor relations mobile iPhone App, called the “SYN IR” App, now available for free at the Apple App Store on the iPhone or iPad or at http://bit.ly/I9xDpW.

WWJ Newsradio 950–04/26/2012

istockphoto

UM Part Of New Study Of Stem Cell Injections in Lou Gehrig’s Disease

The first published results from an early-stage clinical trial show that spinal cord stem cells can be delivered safely into the spines of patients with the condition commonly known as Lou Gehrig’s disease, opening the door for further research on this innovative approach.

WWJ Newsradio 950–04/10/2012

adeona2

Adeona Reports Positive Study Results For Zinc Treatment Of ALS

Pharma startup Adeona and its research partner report no safety issues related to high doses of zinc to slow the effects of Lou Gehrig’s Disease

WWJ Newsradio 950–11/30/2011

UM Research May Help Treat ALS

In cells, as in cities, disposing of garbage and recycling anything that can be reused is an essential service. In both city and cell, health problems can arise when the process breaks down. New research […]

07/14/2010

Follow

Get every new post delivered to your Inbox.

Join 1,865 other followers